
TreeFrog Therapeutics is a stem cell company that will enable millions of patients to access the medical revolution of cell therapies by overcoming current critical manufacturing issues. TreeFrog Therapeutics has developed C-Stem® : a proprietary technology platform that provides an end to end 3D scalable solution that will dramatically reduce treatment costs. Through strategic partnership and co-developments, TreeFrog Therapeutics will help cell therapy players to secure cell production and quality, fasten clinical development and facilitate market access
Investment Date
2019
Country
France
Sector
Biotech
Investor(s)

Guilhem de Vregille
Partner Paris
1 job
Fluidic Scientist/Senior Fluidic Scientist
3D Printing
Liver
Biotechnology
Mammalian Cell Culture
Rheology
Early-Stage
Biology
Research
Processes Development
CAD
Diabetes
Computational Fluid Dynamics
Cell Therapy
Fluid Mechanics
Pharmaceutical Industry
3D
IPS
Attention to Detail
Cambridge, MA177 EmployeesScience
Posted 14 days ago